BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


Catachem Announces FDA Approval of the Total Bilirubin (TBILI) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit

Bridgeport, Connecticut, USA (April 10, 1989)…. Catachem, Inc. (Private) announced today that it has received 510k clearance from the United States Food and Drug Administration (FDA) for the Total Bilirubin (TBILI) in vitro diagnostic chemistry reagent kit.

Measurements of Total Bilirubin (TBILI) in blood are used for diagnosing obstructive jaundice and hepatitis, as well as to monitor the causes and treatment.  Total bilirubin levels are elevated in babies with jaundice. Total bilirubin (direct bilirubin plus indirect bilirubin) is often measured by itself. If the total bilirubin result is abnormally high, the direct and indirect forms of bilirubin are then usually measured separately to provide more information. Bilirubin is a brownish yellow substance found in bile. Bilirubin is produced when the liver breaks down hemoglobin, the oxygen-carrying substance in red blood cells. Bilirubin is then removed from the body through the stool (feces) and gives stool its normal brown color. Bilirubin circulates in the bloodstream in two forms: Indirect (or unconjugated) bilirubin. This form of bilirubin does not dissolve in water (it is insoluble). Indirect bilirubin travels through the bloodstream to the liver, where it is changed into a soluble form.  Direct (or conjugated) bilirubin. After indirect bilirubin has been changed by the liver into a form that dissolves in water (soluble), it is called direct or conjugated bilirubin. Total bilirubin and direct bilirubin levels are measured directly in the blood, whereas indirect bilirubin levels are derived from the total and direct bilirubin measurements.  The most obvious symptom of high bilirubin levels is jaundice, a condition in which the skin and whites of the eyes appear yellow. Jaundice is caused by the buildup of bilirubin in the blood and skin from liver disease (hepatitis), blood disorders (haemolytic anemia), or blockage of the tubes (bile ducts) that allow bile to pass from the liver to the small intestine.  Excessive buildup of bilirubin in a newborn baby sometimes causes brain damage and even death. Therefore, some babies who develop jaundice may be treated with special lights or a blood transfusion to reduce their bilirubin levels.  This test is done on a blood sample taken from a vein. In a newborn baby, the blood sample is usually taken from the heel (heel stick).  Bilirubin from the serum sample mixes with diazotized sulfanilic acid to form an azo-bilirubin complex.   The increase in absorbance is monitored at 550 nm. TBILIB is a two reagent chemistry and kits are available for R2 and reagents are available for R1 separately.  Reagents are packaged in small glass bottles. Calibrator and controls are available separately.  TBILIB R2 Kit C314-0B        530 tests, TBILIB Reagent: TBILIB R1 C314-04 1x500 ML.

About Catachem, Inc.

Founded in 1984 Catachem has a rich 20 year history in clinical chemistry as a manufacturer and distributor of in-vitro chemistry products and services for assays in human, veterinary and environmental laboratories. Catachem chemists helped develop many of the automated diagnostic chemistries widely in use today.  Catachem created the DiscretePak™ and VetSpec™ line of reagents for human diagnostic and veterinary diagnostic automated analyzers.  Catachem offers FDA approved (510K) chemistries (liquid and dry) including enzymatic chemistries developed in conjunction with IFCC and CDC.  Catachem has more than 500 applications for all types of analyzers including the Roche Hitachi series, OlympusAU Series, RA Series, Opera and DAX, BayerAdvia™, Synchron, Beckman, Abbott and many other analyzers.  Corporate headquarters, research, custom formulation laboratories, and manufacturing are located in Bridgeport, Connecticut.  Catachem supplies leading laboratories and equipment manufacturers from distributors around the world. 

Forward-looking statements in this release are made pursuant to the ``safe harbor'' provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialization and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.

Keywords: Catachem, Chemistry, Reagents, In-Vitro Diagnostics, IVD, Total Bilirubin, TBILI, haemolytic anemia, hepatitis

For more information contact:

Benjamin Twombly

Catachem, Inc.
70 Hawley Avenue
Bridgeport, CT
USA 06606
+1 (203) 335-9277 Office
+1 (203) 335-9977 FAX
bentwombly@aol.com
catachem@aol.com
www.catacheminc.com

 

Ref: C3108a

 

Catachem chemistries include: 5'-Nucleotidase (5NT), Adenosine Deaminase (ADA), Alanine Aminotransferase (ALT), Albumin BCG (ALB), a-L-Fucosidase (AFU), Alkaline Phosphatase (ALP), Ammonia (NH), Amylase (AMY), Aspartate Aminotransferase (ALP), β-Hydroxybutyrate (BHBA), Bicarbonate (HC03), Bile Acids (BA), Bilirubin, Direct with Blank (DBILI), Bilirubin, Total with Blank (TBILI), Bilirubin, Total (TBILI), Blood Urea Nitrogen (BUN), Bromide (BR), CO2 [340] (CO2), CO2 [380] (CO2), CO2 [single reagent] (CO2), Ca+++ Arsenazo [650NM] (CA3), Chloride [340 NM] (CL), Cholesterol (CH), Creatine Kinase (CK), Creatinine (CREAT), Fructosamine [millimole method] (FR), Fructosamine, Glycated Serum Protein [enzymatic] (FR), Gamma-Glutamyl Transpeptidase (GGT), Glucose Hexokinase (GLU), Glycated Hemoglobin (HbA1c), High Density Lipoproteins, Dextran Sulfate (HDL), Inorganic Phosphorus (IP), Lactate Dehydrogenase (LD), Lipase (LIP), Lithium [enzymatic] (LI), Magnesium (MG), N-Acetyl-ß-D-glucosaminidase (NAG), Potassium [enzymatic] (K), Plasma Free Hemoglobin (PFH), Pre-albumin (TBPA), Sodium [enzymatic] (NA), Sorbitol Dehydrogenase (SDH), Thiopurine methyltransferase (TPMT), Total Bile Acids (TBA), Total Iron (TI), Total Protein (TP), Triglycerides (TRIG), UIBC and TIBC (UIBC), Uric Acid (UA), Vitamin B6 (V6B), Multipoint Calibrator Catacal, Catatrol Level 1 Catatrol Level 2, Bile Acids Control, Bile Acids Calibrator, BHBA Calibrator, BHBA Control Level 1, BHBA Control Level 2; Bromide Calibrator, BR Control Level 1, BR Control Level 2; Fructosamine Calibrator, FR Control Level 1, FR Control Level 2, SDH Control Level 1, SDH  Control Level 2.  Call +1 (203) 335-9277 or Write Catachem@aol.com.

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.